Avita Medical, Mena United sign JV for ReCell Spray-On Skin
The JV, registered in Kuwait as Avita Medical Mena (AVM), will be 70% controlled by Avita Medical. AVM will be responsible for sales and marketing efforts in the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.